mod grf 1-29 252917-06-9 Senwayer New Product
10 Inquiries
252917-06-9
Pharmaceutical Grade
99%
wuhan
Senwayer
1g/vial
Yes
2027-06-19
API,nutrition supplements,plant extract,peptide,HCG,6-Aminocaproic acid
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceCHIR-99021 is a GSK-3α/β inhibitor with an IC50 of 10 and 6.7 nM,showing 500-fold selectivity over its closest homologs CDC2 and ERK2, as well as other protein kinases.
CHIR 99021 is a member of the class of aminopyrimidines that is 2-aminopyrimidine substituted at positions N2, 5 and 6 by (5-cyanopyridin-2-yl)ethyl, 4-methylimidazol-2-yl and 2,4-dichlorophenyl groups respectively. It has a role as an EC 2.7.11.26 (tau-protein kinase) inhibitor. It is a member of imidazoles, a dichlorobenzene, an aminopyrimidine, an aminopyridine, a cyanopyridine, a secondary amino compound and a diamine.Basic Info-
Product Name:
GSK 3 inhibitor XVI
Other Name:3-Pyridinecarbonitrile,6-[[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-;3-Pyridinecarbonitrile,6-[[2-[[4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-;6-[[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-3-pyridinecarbonitrile;CHIR 99021;CT 99021;CHIR 911;CIHR 99021;CHIR 99201;GSK 3 inhibitor XVI;GSK 3IXV;Laduviglusib;1485056-50-5
CAS No.:252917-06-9
Molecular Formula:C22H18Cl2N8
InChIKeys:InChIKey=AQGNHMOJWBZFQQ-UHFFFAOYSA-N
Molecular Weight:465.35
Exact Mass:465.34
EC Number:1312995-182-4
UNII:234CMT4GK4
DSSTox ID:DTXSID90179931
HScode:29335990
Categories:
Characteristics-
PSA:
115
XLogP3:4.3
Appearance:white to light brown
Density:1.5±0.1 g/cm3
Boiling Point:784.1±70.0°C at 760 mmHg
Flash Point:428.0±35.7 °C
Refractive Index:1.700
Water Solubility:DMSO: soluble2mg/mL, clear (warmed)
Storage Conditions:-20°C
Research-
Class:
GHRH analog (1–29 amino-terminal fragment, 29-amino-acid peptide amide)
Status:FDA-approved diagnostic agent (Geref, discontinued). NOT for therapeutic use.
Mechanism:A synthetic 29-amino-acid peptide (H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂) identical to the amino-terminal segment of endogenous human GHRH. Sermorelin binds to the GHRH receptor (GHRHR) on anterior pituitary somatotrophs, stimulating pulsatile GH synthesis and secretion via the cAMP/PKA pathway. Unlike exogenous GH, sermorelin preserves the endogenous GH pulsatility and IGF-1 feedback loop.
EC50 (Ghrhr Ec50):~0.1–1 nM (cAMP accumulation in rat pituitary cells)
Source:DrugBank: DB00010. Frohman LA, et al. Endocr Rev. 1986;7(3):223–253.DOI
Clinical Development:FDA:Geref (approved 1991-10-11)
References-
ChEMBL:
CHEMBL1201555
DrugBank:KEGG DRUG:D08554
PubChem:Literature:Disclaimer:Sermorelin was FDA-approved as a diagnostic agent (Geref) for growth hormone deficiency but has been discontinued (not for safety reasons). It is NOT approved for anti-aging, bodybuilding, or therapeutic GH replacement. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 2, Oral
Skin irritation, Category 2
Eye irritation, Category 2
Specific target organ toxicity â single exposure, Category 3
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Danger
Hazard statement(s) H300 Fatal if swallowed
H315 Causes skin irritation
H319 Causes serious eye irritation
H335 May cause respiratory irritation
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P271 Use only outdoors or in a well-ventilated area.
Response P301+P316 IF SWALLOWED: Get emergency medical help immediately.
P321 Specific treatment (see ... on this label).
P330 Rinse mouth.
P302+P352 IF ON SKIN: Wash with plenty of water/...
P332+P317 If skin irritation occurs: Get medical help.
P362+P364 Take off contaminated clothing and wash it before reuse.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P319 Get medical help if you feel unwell.
Storage P405 Store locked up.
P403+P233 Store in a well-ventilated place. Keep container tightly closed.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
API,nutrition supplements,plant extract,peptide,HCG,6-Aminocaproic acid
-
Location:
Room 707, Block A, Zhongxing Times Digital Trade Port, No. 79 Xudong Street, Hongshan District, Wuhan City
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
10 days
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
51-100
-
Year of Establishment:
2020
Company Certificates-
Verified supplier certificate
-
SGS
-
-
Inquiry History10 Inquiries
Country Product Purchase Quantity Date Posted
Canada
252917-06-9
1 KG Mar 24, 2026
Russia
Pharmaceutical Chemical Anti-hair loss CHIR99021 CAS NO 252917-06-9 in stock 99% white powder
10 G Mar 7, 2025
Russia
chir-99021
3 G Apr 30, 2025
Poland
GSK 3 inhibitor XVI
1 G Oct 12, 2026
Russia
mod grf 1-29
1 G Mar 13, 2025
United Kingdom
GSK 3 inhibitor XVI
100 G Sep 23, 2026
Singapore
CHIR-99021
1 G Sep 1, 2026
Australia
Chir99021
1 G Jul 13, 2026
Brazil
Na-931 Bioglutide
5 MG Sep 3, 2025
Russia
CHIR99021
10 G Mar 4, 2025 Post an enquiry for this product
More from this Seller
-
-
-
Bulk Price AC-262536 CAS 870888-46-3 with High 99% Purity
Pharmaceutical Grade / 99%
-
-
-
-
Retinoic acid Tretinoin 99% Powder Pharmacy Grade C20H28O2 Top Purity Senwayer
Pharmaceutical Grade / 99%
-
-
-
-
HYDROXYLAMINE 50% liquid 7803-49-8 Senwayer
Pharmaceutical Grade / 50%
-
-
-
-
Nystatin 99% yellow powder 1400-61-9 Senwayer
Pharmaceutical Grade / 99%
-
-
-
-
Sodium thiosulfate 99% Colorless crystals Na2O3S2 Senwayer
Pharmaceutical Grade / 99%
-
-
-
-
o-Carborane 99% white powder 16872-09-6 Senwayer
Pharmaceutical Grade / 99%
-